Mesenchymal Stem Cells: An Excellent Candidate for the Treatment of Diabetes Mellitus
Mesenchymal stem cells (MSCs) are adult stem cells (ASCs) known for repairing damaged cells, exerting anti-inflammatory responses and producing immunoregulatory effects that can be significantly induced into insulin-producing cells (IPCs), providing an inexhaustible supply of functional β cells for...
Saved in:
Main Authors: | Qiulan Huang, Yanting Huang, Jianping Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-01-01
|
Series: | International Journal of Endocrinology |
Online Access: | http://dx.doi.org/10.1155/2021/9938658 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Potential of Mesenchymal Stem Cell-Derived Exosomes to Treat Diabetes Mellitus
by: Ju-El Kim, et al.
Published: (2025-01-01) -
Research Progress on Mesenchymal Stem Cells for the Treatment of Diabetes and Its Complications
by: Jiarui Zhang, et al.
Published: (2023-01-01) -
Targeting ferroptosis: opportunities and challenges of mesenchymal stem cell therapy for type 1 diabetes mellitus
by: Le Dai, et al.
Published: (2025-02-01) -
Regenerative Therapy of Type 1 Diabetes Mellitus: From Pancreatic Islet Transplantation to Mesenchymal Stem Cells
by: Nadine E. Rekittke, et al.
Published: (2016-01-01) -
Umbilical cord mesenchymal stem cells improve bone regeneration in diabetes mellitus animal model with apical periodontitis
by: Eric Priyo Prasetyo, et al.
Published: (2025-01-01)